Literature DB >> 16998376

Peritoneal carcinomatosis of colorectal origin: standard of care.

Tristan D Yan.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16998376      PMCID： PMC1856561          DOI： 10.1097/01.sla.0000239629.96036.cd

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  17 in total

1.  Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

Authors:  Deborah K Armstrong; Brian Bundy; Lari Wenzel; Helen Q Huang; Rebecca Baergen; Shashikant Lele; Larry J Copeland; Joan L Walker; Robert A Burger
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

2.  Decreasing the risk of a treatment expands its indications.

Authors:  Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2005-09-21       Impact factor: 5.344

3.  Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study.

Authors:  A L A Bloemendaal; V J Verwaal; S van Ruth; H Boot; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2005-08-03       Impact factor: 4.424

Review 4.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

5.  Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.

Authors:  D Z Chu; N P Lang; C Thompson; P K Osteen; K C Westbrook
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

6.  Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases.

Authors:  S Schneebaum; M W Arnold; A Staubus; D C Young; D Dumond; E W Martin
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

7.  Long-term survival of peritoneal carcinomatosis of colorectal origin.

Authors:  Vic J Verwaal; Serge van Ruth; Arjen Witkamp; Henk Boot; Gooike van Slooten; Frans A N Zoetmulder
Journal:  Ann Surg Oncol       Date:  2004-12-27       Impact factor: 5.344

8.  Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.

Authors:  D M Kecmanovic; M J Pavlov; M S Ceranic; A V Sepetkovski; P A Kovacevic; A B Stamenkovic
Journal:  Eur J Surg Oncol       Date:  2005-03       Impact factor: 4.424

9.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

Authors:  O Glehen; F Kwiatkowski; P H Sugarbaker; D Elias; E A Levine; M De Simone; R Barone; Y Yonemura; F Cavaliere; F Quenet; M Gutman; A A K Tentes; G Lorimier; J L Bernard; J M Bereder; J Porcheron; A Gomez-Portilla; P Shen; M Deraco; P Rat
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

10.  Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  O Glehen; E Cotte; V Schreiber; A C Sayag-Beaujard; J Vignal; F N Gilly
Journal:  Br J Surg       Date:  2004-06       Impact factor: 6.939
View more
  3 in total

Review 1.  Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

Authors:  Hassan-Alaa-Hammed Al-Shammaa; Yan Li; Yutaka Yonemura
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 2.  Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.

Authors:  F Losa; P Barrios; R Salazar; J Torres-Melero; M Benavides; T Massuti; I Ramos; E Aranda
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

3.  Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only.

Authors:  Grégoire Désolneux; Camille Mazière; Jérémy Vara; Véronique Brouste; Marianne Fonck; Dominique Béchade; Yves Bécouarn; Serge Evrard
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.